                         SEQUENCE LISTING

<110>  De Staat der Nederlanden vertegenwoordigd door de 
       Ministerie van VWS
 
<120>  Vaccine against amyloid folding intermediate

<130>  P6021165EP

<150>  EP 08159385.7
<151>  2008-07-01

<150>  US 61/077,264
<151>  2008-07-01

<160>  4     

<170>  PatentIn version 3.3

<210>  1
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Glu, Gly, Gln or Lys

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa = Asp or Asn

<400>  1

Xaa Xaa Xaa Val Ser Gly Asn 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = Glu, Gly, Gln or Lys

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Asp or Asn

<400>  2

Xaa Xaa Val Ser Gly Asn Lys 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = Asp or Asn

<400>  3

Xaa Val Ser Gly Asn Lys Gly 
1               5           


<210>  4
<211>  42
<212>  PRT
<213>  Homo sapiens

<400>  4

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys 
1               5                   10                  15      


Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile 
            20                  25                  30          


Gly Leu Met Val Gly Gly Val Val Ile Ala 
        35                  40          


